Sep 11, 2026 02:00PM

Sep 11, 2026 02:00PM

Jun 4, 2026 01:00AM

Mar 12, 2026 11:53AM

Oct 2, 2025 06:44AM

Oct 1, 2025 01:00AM

Oct 1, 2025 01:00AM Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years

Dec 12, 2024 06:44AM

Oct 28, 2024 08:20AM

May 8, 2024 01:00AM

Nov 21, 2023 01:00AM

Aug 9, 2023 01:00AM

Jun 26, 2023 12:00PM

Jun 1, 2023 01:00AM Pharming announces sale of priority review voucher

May 11, 2023 01:00AM

Apr 11, 2023 01:00AM

Mar 24, 2023 02:33PM

Mar 24, 2023 02:30PM

Feb 21, 2023 01:00AM

Feb 16, 2023 01:00AM

Dec 15, 2022 01:00AM Pharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition

Sep 28, 2022 01:00AM

330,742 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All